Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BrainCool AB (publ) has completed the recruitment in the Nordic clinical study with Cooral® System to prevent oral mucositis (OM)

The recruitment to the Nordic study to prevent oral mucositis is now completed. The study is a controlled, randomized Nordic study of 180 patients treated with powerful cytostatic therapy due to malignant blood disorders. In the study, BrainCool's product Cooral® System was evaluated to prevent troublesome mucosal damage in the oral cavity and pharynx (oral mucositis, OM). “The completed recruitment is an important milestone for BrainCool and Cooral® System. I am extremely grateful for the team's hard work at the clinics”- says Martin Waleij, CEO of BrainCool AB. The analysis of the

Teleste continues collaboration for Smart City solutions as a part of the LuxTurrim5G ecosystem

Turku, Finland – 7 November 2019 – Teleste continues building key enablers for the smart and safe city in the LuxTurrim5G ecosystem project that has entered its second phase  and is moving towards productization and practical piloting of 5G based smart city innovations. With a special focus on the needs for public safety and intelligent public transport, Teleste collaborates with altogether 26 ecosystem partners in the two-year intensive co-development driven by Nokia and coordinated by

STENOCARE sign supply agreement with Emerald Health Therapeutics Inc

STENOCARE A/S (“STENOCARE”) hereby announce that the company has signed a new agreement to source medical cannabis for Denmark and the company’s international markets with the Canadian company Emerald Health Therapeutics Inc (“Emerald”) (TSXV: EMH; OTCQX: EMHTF). STENOCARE and Emerald will immediately commence the work with the Danish Medicines Agency (“DMA”) to have the products approved for the Danish Medical Cannabis Pilot Programme.STENOCARE has carefully evaluated potential new suppliers of medical cannabis in order to supply products suitable for patients according to the strict

Change in Valmet Oyj’s holding of treasury shares

Valmet Oyj’s stock exchange release on November 7, 2019 at 2:00 p.m. EET On November 7, 2019 a total of 472 Valmet shares have been returned free of consideration to Valmet Oyj according to the terms and conditions of the long-term incentive plan 2018-2020. Originally, the shares were transferred to the participants after the 2018 performance period of the plan. Including the returned shares, Valmet Oyj now holds a total of 246,096 treasury shares. Further information, please contact:Pekka Rouhiainen, Director, Investor Relations, Valmet, tel. +358 10 672 0020 VALMET Kari

Norway Royal Salmon (NRS): Invitation to presentation of Q3 2019

Norway Royal Salmon will present the interim report for the 3rd quarter 2019 on Tuesday 12th November 2019 at hrs 08:00 CET at Hotel Continental, Stortingsgaten 24/26 in Oslo. The company’s CEO Charles Høstlund and CFO Ola Loe will announce the results. Please note that the quarterly report and presentation will be published at 06:30 CET. For further information, please contact:CFO Ola LoeTlf: +47 911 79 411E-mail: ola.loe@salmon.no

BerGenBio to present clinical data from Phase II combination trial of bemcentinib and LDAC trial in elderly AML patients at ASH 2019

Bergen, Norway, 7 November 2019 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for multiple cancer indications, is pleased to announce it has been accepted for a poster presentation at the 61st Annual American Society of Hematology (ASH) Meeting, which takes place from 7-10 December 2019 in Orlando, Florida. The poster will provide an update on its phase II study of bemcentinib (BGB324) in combination with Low-dose Cytarabine in elderly AML patients. Abstract titles have been announced online 

Invent Medic receives first Efemia order from a Swedish public health care region

Invent Medic announces that the company has received the first order for the product Efemia Bladder Support from a Swedish public health care region. The order shows that health care entities value the benefits of Efemia as a non-surgical, effective and easy-to-use solution for women with stress urinary incontinence (SUI).As stated in Invent Medic’s recently published interim report, the company is a registered as a provider for two Swedish health care regions. The registration enables these regions to order Efemia before finalising public procurements. In addition to being registered as

Troax Group Interim report January- September 2019

Hillerstorp 7th of November  2019, 12:30 CETJULY - SEPTEMBER · Order intake was unchanged compared to prior year and amounted to 40,0 (40,1) MEUR. · Sales increased organically by 6 per cent to 42,2 (39,7) MEUR. Adjusted for currency the increase was 6 per cent. · Operating profit increased to 9,8 (8,6) MEUR. · Operating margin increased to 23,2 (21,7) per cent. · Financial net was -0,3 (-0,3) MEUR. · Profit after tax increased to 7,3 (6,3) MEUR. · Earnings per share after dilution amounted to 0,12 (0,11) EUR based on 60 000 000 shares regarding both periods. (a split

Invitation to Embracer Group’s Q2 presentation

Embracer Group hereby invites you to a presentation in connection with the publishing of the second quarterly report for the financial year, July-Sep 2019. The report will be published the same morning, well before the market opens.The presentation will be held in English by CEO Lars Wingefors and afterwards questions are invited. Date: November 14, 2019 Time: 09:00-10:00 (CET) Place: Carnegie Hall, Regeringsgatan 56, Stockholm or via webcast and teleconference. Please register for participation in person at Carnegie Hall: https://financialhearings.com/event/11778 Questions

Citycon Oyj announces conditional tender offer for NOK-denominated bonds issued by Citycon Treasury B.V.

CITYCON OYJ   Inside information   7 November 2019 at 13:00 hrsNOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT. Citycon Oyj (the Offeror) hereby announces a conditional tender offer for up to NOK 900 million nominal outstanding amount of the NOK

Citycon Oyj considers issuance of green Capital Securities

CITYCON OYJ   Inside information   7 November 2019 at 13:00 hrsNOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Citycon Oyj (“Citycon”) is considering issuance of euro-denominated green capital securities (“Capital Securities”) in an amount of up to

Interim report January – September 2019

Continued high profitability and geographic expansionJuly – September 2019 · Net sales increased 41.9 percent to SEK 1,416 (998) million. Organic growth was 14.6 (8.6) percent. · Adjusted EBITA increased to SEK 127 (75) million, which corresponds to an adjusted EBITA margin of 9.0 (7.5) percent. · Operating cash flow for the quarter was SEK 138 (25) million. · Five acquisitions were made during the quarter, which, on an annual basis, contribute an estimated total sales of SEK 359 million. · Earnings per share for the quarter amounted to SEK 1.59 (1.22). January –

Citycon Oyj commences tender offers for three series of bonds

CITYCON OYJ   Inside information   7 November 2019 at 13:00 hrsNOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE

Planmeca PlanID™ sign-in system receives Innovation 2019 honorable mention

The unique sign-in system of Planmeca dental units has been awarded with an Innovation 2019 honorable mention at the Finnish Dental Congress and Exhibition in Helsinki. The Dental Industry Innovation Award has been handed out at the Dental Congress and Exhibition which is currently underway in Helsinki. The award is given to a company or a society that has strived to improve the working conditions of dental professionals, the safety of patients or the overall quality of care. The award winners are chosen by a jury consisting of dental care experts. The Planmeca PlanID™ sign-in system

Correction: Notice to attend the Annual General Meeting

NextCell Pharma AB ("NextCell") announces that a notice of the Annual General Meeting for the 2018-2019 financial year has been published. Compared to the press release published this morning, corrections have been made regarding the Market Abuse Regulation label. The information is not subject to the Market Abuse Regulation.The annual general meeting will be held on December 5, 2019 at 10.00 at Novum, Hälsovägen 7, Huddinge. The notice has been published in Svenska Dagbladet and Post and Inrikes Tidningar as well as on the company's website, www.nextcellpharma.com. The Annual Report and

Cederquist has represented SKL Företag AB in connection with its divestment of Dagens Samhälle AB

Cederquist has represented SKL Företag AB in connection with its divestment of Dagens Samhälle AB to Tidnings AB Marieberg, a company part of the Bonnier group. For further information, please see https://skl.se/tjanster/press/nyheter/nyhetsarkiv/dagenssamhallefarnyagare.29945.html.Cederquist’s team was led by capital markets and M&A partner Wilhelm Lüning, together with Magnus Staaf, senior associate (M&A), Fredrik Bengtsson, associate (M&A), and Alexandra Kärnekull, associate (M&A).

Interim Report January – September 2019

· Gross profit from property management rose by 6 per cent to SEK 1,029 million (972). The increase can be attributed mainly to higher rental revenue. · Net revenue from property management amounted to SEK 1,408 million (1,333), an increase of 6 per cent. · Profit after tax for the period was SEK 2,045 million (3,137), equivalent to SEK 9.91 per share (15.21). The decrease can be attributed mainly to lower unrealized changes in the value of the property holdings and the deferred tax recalculation the previous year following the reduction in corporation tax.    · The fair

Bosnia and Herzegovina developing new environmental strategy and action plan with Swedish support

Bosnia and Herzegovina (BiH) is preparing an environmental strategy and action plan for 2030 and beyond, with support from Stockholm Environment Institute, the Swedish Embassy in BiH and the Swedish International Development Cooperation Agency, Sida. The project was launched on Wednesday with a tree-planting event in Sarajevo attended by HRH Crown Princess Victoria of Sweden, Swedish Environment Minister Isabella Lövin, and high-level officials from BiH.The new BiH Environmental Strategy and Action Plan 2030+ (ESAP 2030+) aims to: · strengthen current environmental governance in BiH

Swedbank is interviewed in the Swedish news programme Uppdrag granskning

Swedbank’s CEO Jens Henriksson has today been interviewed by the Swedish news programme Uppdrag granskning. The interview is a follow-up on previously aired programmes about suspected money-laundering.The interview is planned to be part of a programme that is to be aired on November 20. In connection with the interview Swedbank has decided to disclose information regarding its Non-Resident Clients in the Baltic Region that previously has been submitted to investigating authorities. In the period 2012 – 2018, the bank estimates that less than 1 percent of the bank’s total profit

Qt Group Plc’s financial reporting and the annual general meeting in 2020

Qt Group Plc Stock Exchange Release November 7, 2019Qt Group Plc will publish its 2019 financial statements on February 14, 2020 at 8:00 am. The financial statements will be published as part of the company's annual report, which contains the report of the Board of Directors, consolidated and parent company financial statements, and the auditor's report for the period January 1 – December 31, 2019. At the same time the Corporate Governance Statement and the remuneration report for the financial year 2019 will be published. Qt Group Plc will publish financial reports in 2020 as follows:-

Lipidor Announces Last Patient Out in Calcipotriol/AKVANO spray (AKP01) Phase III Study Targeting Psoriasis

Lipidor AB (publ) today reports that the last patient has completed treatment in the phase III study evaluating the efficacy of using a sprayable calcipotriol product against mild to moderate psoriasis. Results from the study are expected to be presented in December 2019.Lipidor has developed a sprayable calcipotriol product, Calcipotriol/AKVANO 50 µg/g cutaneous solution (AKP01), formulated with the company’s lipid-based technology in order to provide more precise dosing, increased comfort, and non-touch treatment to patients. The phase III study is a comparative, randomized and placebo-

The MIRAGE project gives Sivers IMA traction in FTTH

Sivers IMA (Nasdaq First North: SIVE) today announced its subsidiary CST Global gains traction within FTTH through the MIRAGE project.The MIRAGE project, which was started in 2015 and government-funded through Scottish Enterprise, has now been finalized after almost four years. The project has helped CST Global develop mid-infrared laser chips for applications in worldwide FTTH (Fiber-to-the-home), sensing, imaging, telecoms and data-centre markets. The MIRAGE project has given access to the expertise and materials required to compete in these markets and has thus helped secure CST Global’s

Outokumpu Fagersta Stainless inaugurates modernized rolling mill

Outokumpu OyjPress ReleaseNovember 7, 2019 Outokumpu has completed a major modernization investment in its Fagersta Stainless mill in Sweden. The investment of 8 million euros enables Fagersta to expand its product portfolio into new high value-added special products, it improves the working environment for the employees and helps to reduce carbon emissions of the mill. The mill was inaugurated today by the Swedish Foreign Trade Minister, Anna Hallberg, Outokumpu’s CEO Roeland Baan and Johan Wiklund, Managing Director, Outokumpu Fagersta Stainless. "The mill in Fagersta, together

Notice to attend the Annual General Meeting

NextCell Pharma AB ("NextCell") announces that a notice of the Annual General Meeting for the 2018-2019 financial year has been published.The annual general meeting will be held on December 5, 2019 at 10.00 at Novum, Hälsovägen 7, Huddinge. The notice has been published in Svenska Dagbladet and Post and Inrikes Tidningar as well as on the company's website, www.nextcellpharma.com. The Annual Report and Audit Report will be available three weeks before the Meeting, November 14, on the Company's website, www.nextcellpharma.com. This information is the information that NextCell Pharma AB

There are no items matching the current filter
There are no more items matching the current filter
Back to top